Indigenously developed DNA Vaccine Candidate by Zydus Cadila, approved for Phase III trials
January 03, 2021
New Delhi: The Nation’s first indigenously developed DNA vaccine candidate against COVID-19, ZyCoV-D, by M/s Zydus Cadila has been approved by Drugs Controller General of India (DCGI), for conduct of the Phase III clinical trials. The candidate has been supported by the National Biopharma Mission (NBM) under the aegis of BIRAC and the Department of Biotechnology, Government of India.
Zydus Cadila completed Phase-I/II clinical trials of this DNA Vaccine candidate, in India, in more than 1,000 participants and interim data indicated that the vaccine is safe and immunogenic when three doses were administered intradermally. Based on the recommendations of the Subject Expert Committee, which reviewed the interim data, the DCGI has accorded permission for conducting Phase-III clinical trial in 26,000 Indian participants.
Dr. Renu Swarup, Secretary, DBT and Chairperson, BIRAC expressed happiness and hoped that the candidate vaccine continues to show positive outcomes. Speaking on the occasion, she said, “The Department of Biotechnology, Government of India has partnered with Zydus Cadila, to address the need for accelerated development of an indigenous vaccine for COVID-19. The partnership exemplifies that such research endeavours demonstrate the Government’s focus on creating an ecosystem that nurtures and encourages new product innovation with societal relevance”. She also mentioned , “The establishment of the Nation’s first DNA vaccine platform is an important milestone for Atma Nirbhar Bharat and a big leap forward for Indian scientific research.”
Related Stories
PM Modi biggest factor behind development of world's first DNA vaccine against Covid: Pankaj Patel of Zydus Cadila
Dr. Sharvil Patel on Zydus on current status on upcoming Covid19 vaccine
Serum Institute and Bharat Biotech Covid19 vaccines get CDSCO approval; Phase-III trials permit to Cadila
PM shared valuable inputs on how to further strengthen vaccine development programme: Zydus Cadila
Prime Minister Modi visits Zydus Biotech Park in Gujarat to review Covid19 vaccine development
PM Modi to visit Zydus Cadila Pharma's vaccine development facility in Gujarat on Saturday: Nitin Patel
Pankaj Patel of Zydus on upcoming human clinical trials for Covid-19 vaccine
DGCI nod to Zydus Cadila for human clinical trials of Covid-19 vaccine
Recent Stories
- 20 years imprisonment to sacked IPS Sanjiv Bhatt for planting drugs
- Movie theater, PG hostel, Game Zone in TRP mall sealed by AMC
- Adani’s copper unit in Mundra begins operations
- Gujarat Super League to Revolutionize Football Landscape in Gujarat
- Patil takes data and mathematics class of party office-bearers in Rajkot
- Gandhinagar Municipal Corporation becomes Congress-mukt
- Panchmahal Congress candidate faces trust deficit among section of party workers